Bharat

Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report

India News | Press Trust of India | Wednesday May 12, 2021

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.

18 States Getting Direct Supply Of Covaxin Since May 1, Says Bharat Biotech

India News | Press Trust of India | Tuesday May 11, 2021

Bharat Biotech on Tuesday said it will continue the steady supply of its COVID-19 vaccine Covaxin, adding the jab has been directly supplied to 18 states since May 1.

डेमलर इंडिया ने अपने चन्नई प्लांट में टीकाकरण केंद्र खोला

Edited by: Shams Raza Naqvi | Tuesday May 11, 2021

चेन्नई के पास ओरगादम में डेमलर के प्लांट में COVID-19 टीकाकरण केंद्र एक दिन में 250 लोगों को टीका लगा पाएगा.

Oil Refiners Cut Output, Imports As COVID-19 Hits Demand

Business | Reuters | Tuesday May 11, 2021

State-run Bharat Petroleum Corp has cut its crude imports by 1 million barrels in May and will reduce purchases by 2 million barrels in June

Indian Oil Refiners Cut Output, Imports As Pandemic Hits Demand

Written by Reuters | Tuesday May 11, 2021

Indian Oil Corp has reduced runs to an average of between 85% and 88% of processing capacity, adding runs could be cut further as its plants at Gujarat, Mathura and Panipat are facing problems storing bitumen and sulphur.

"Share Vaccine Formula," Arvind Kejriwal Suggests To PM Modi Amid Shortage

Delhi News | Reported by Sharad Sharma, Edited by Chandrashekar Srinivasan | Tuesday May 11, 2021

Delhi Chief Minister Arvind Kejriwal on Tuesday called on the centre to allow more companies to produce Covid vaccines - of which there is a national shortage as the Serum Institute and Bharat Biotech scramble to match demand amid the second wave

Stocks To Watch: InterGlobe Aviation, JMC Projects

Business | Edited by Peter Noronha | Tuesday May 11, 2021

InterGlobe Aviation, parent of the country's largest airline IndiGo, said that its board has approved raising up to Rs 3,000 crore through sale of shares to institutional investors

Maharashtra NCP Chief Seeks Bharat Ratna For Karmaveer Bhaurao Patil

India News | Press Trust of India | Sunday May 9, 2021

Maharashtra minister and state NCP chief Jayant Patil on Sunday reiterated his party's demand that Bhaurao Patil, popularly addressed as ''Karmaveer'', be bestowed with the Bharat Ratna, the country's highest civilian honour.

Industry Should Start Working On Artificial Intelligence, Data Science Seriously: Sanjay Dhotre

Education | Reported by Press Trust of India | Friday May 7, 2021

The government is keen on utilising the latest technologies like artificial intelligence (AI), machine-to-machine communications and data science, and the industry should start working on them seriously for achieving the goal of Aatmanirbhar Bharat, Union Minister Sanjay Dhotre said.

Oxygen Crisis: IIT Kanpur Team Launches Challenge To Develop Solutions

Education | Edited by Bishal Kalita | Wednesday May 5, 2021

A team at the Startup Incubation and Innovation Centre (SIIC), Indian Institute of Technology (IIT) Kanpur, has launched 'Mission Bharat O2' challenge to bring forward indigenous solutions for solving India's oxygen crisis amid the second wave of the COVID-19 pandemic.

Indian Oil, Bharat Petroleum, HPCL Gain After Petrol, Diesel Price Hike

Business | Edited by Abhishek Vasudev | Tuesday May 4, 2021

Indian Oil shares rose as much 1.63 per cent, Bharat Petroleum climbed 2 per cent and Hindustan Petroleum rose 3.2 per cent.

Ayushman Bharat Diwas 2021: 10 Things To Know About PM-Jan Arogya Yojana

India News | Edited by Debjani Chatterjee | Thursday April 29, 2021

Ayushman Bharat Diwas: April 30 is observed as Ayushman Bharat Diwas. Know about Ayushman Bharat Yojna and PM-Jan Arogya Yojana or PM-JAY, a key part of the biggest health scheme in the world

Covaxin Prices Reduced For States Day After Covishield Prices Cut

India News | Edited by Debanish Achom | Thursday April 29, 2021

Bharat Biotech has reduced the price of its Covaxin for state governments from Rs 600 to Rs 400 per dose, the vaccine-maker said in a statement today. The cost of the COVID-19 vaccine for private hospitals is changed at Rs 1,200 per dose.

Covaxin "Found To Neutralise" Indian 617 Variant: US Adviser Dr. Fauci

India News | NDTV News Desk | Wednesday April 28, 2021

Covaxin, India's home-grown Covid vaccine produced by Bharat Biotech, has been found to neutralise the B.1.617 variant or the Indian double mutant strain, White House Chief Medical Adviser Anthony Fauci said on Tuesday.

Coronavirus India Highlights: 3.6 Lakh Cases, 3,293 Deaths In India In Biggest Spike In 24 Hours

India News | NDTV | Thursday April 29, 2021

Covaxin, India's home-grown Covid vaccine produced by Bharat Biotech, has been found to neutralise the B.1.617 variant or the Indian double mutant strain, White House Chief Medical Adviser Anthony Fauci said on Tuesday.